Flavio C. Lombardo

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.

Journal: NPJ precision oncology

Published: June 12, 2025

Binary classification of gynecological cancers based on ATR-FTIR spectroscopy and machine learning using urine samples.

Binary classification of gynecological cancers based on ATR-FTIR spectroscopy and machine learning using urine samples.

Journal: Clinical and experimental medicine

Published: March 18, 2025

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

Journal: Nature communications

Published: March 09, 2025

Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming.

Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming.

Journal: Nature communications

Published: December 20, 2024

Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models.

Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models.

Journal: STAR protocols

Published: February 08, 2024

Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer.

Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer.

Journal: Cell death & disease

Published: April 26, 2022

Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways.

Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways.

Journal: Cell reports

Published: February 04, 2022

Evaluation of Human Liver Microtissues for Drug Screening on Schistosoma mansoni Schistosomula.

Evaluation of Human Liver Microtissues for Drug Screening on Schistosoma mansoni Schistosomula.

Journal: ACS infectious diseases

Published: October 27, 2020

Parallelized Impedance-Based Platform for Continuous Dose-Response Characterization of Antischistosomal Drugs.

Parallelized Impedance-Based Platform for Continuous Dose-Response Characterization of Antischistosomal Drugs.

Journal: Advanced biosystems

Published: December 20, 2019

Activity and pharmacokinetics of a praziquantel crystalline polymorph in the Schistosoma mansoni mouse model.

Activity and pharmacokinetics of a praziquantel crystalline polymorph in the Schistosoma mansoni mouse model.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: February 22, 2019

Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment.

Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment.

Journal: International journal of molecular sciences

Published: February 18, 2019

Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni.

Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni.

Journal: Nature protocols

Published: January 06, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026